Recombinant MUC16 (Sofituzumab Biosimilar) antibody
The Humanized Chimeric anti-MUC16 (Sofituzumab Biosimilar) antibody is suitable to detect MUC16 (Sofituzumab Biosimilar) in samples from Human.
Catalog No. ABIN7597996
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant MUC16 (Sofituzumab Biosimilar) antibody (ABIN7597996)
Target
MUC16 (Sofituzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This MUC16 (Sofituzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Sofituzumab Biosimilar Antibody
-
Specificity
- Mucin-16, CA-125, Ovarian carcinoma antigen CA125, CA125, MUC-16, Ovarian cancer-related tumor marker CA125, MUC16
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- MUC16 (Sofituzumab Biosimilar)
-
Alternative Name
- Sofituzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Mucin-16, CA-125, Ovarian carcinoma antigen CA125, CA125, MUC-16, Ovarian cancer-related tumor marker CA125, MUC16
-
UniProt
- Q8WXI7
-
CAS-No
- 1615692-28-8
Target
-
You are here:
